BRIEF published on 09/08/2026 at 07:35, 14 days 8 hours ago GenSight Biologics: Review and Outlook as of September 2026 GenSight Biologics Gene Therapies REVISED STUDY LUMEVOQ® Manufacturing Access Programs
BRIEF published on 09/08/2026 at 07:35, 14 days 8 hours ago GenSight Biologics : Bilan et Perspectives de Septembre 2026 GenSight Biologics Thérapies Géniques Étude REVISE Fabrication LUMEVOQ® Programmes D'accès
PRESS RELEASE published on 09/08/2026 at 07:30, 14 days 8 hours ago Inside Information / Other news releases GenSight Biologics provides business updates on manufacturing, clinical activities, and financial status for September 2026, including progress on gene therapy treatments Financial Updates Manufacturing Business Updates Clinical Activities GenSight Biologics
PRESS RELEASE published on 09/08/2026 at 07:30, 14 days 8 hours ago Informations privilégiées / Autres communiqués GenSight Biologics fait un point sur ses activités de fabrication, cliniques et financières, confirmant la date de publication des comptes semestriels 2026 Fabrication GenSight Biologics Thérapies Géniques Comptes Semestriels Actifs Cliniques
BRIEF published on 07/08/2026 at 19:16, 2 months 13 days ago GenSight Biologics presents its financial situation and therapeutic advances Treasury GenSight Biologics Phase III RECOVER Early Access GS010/LUMEVOQ®
BRIEF published on 07/08/2026 at 19:16, 2 months 13 days ago GenSight Biologics Announces Cash Position and Business Updates Cash Position Clinical Trials Business Updates Early Access Programs Manufacturing Process
BRIEF published on 07/08/2026 at 19:16, 2 months 13 days ago GenSight Biologics annonce sa situation de trésorerie et des mises à jour sur ses activités Essais Cliniques Actualités Commerciales Position De Trésorerie Programmes D'accès Anticipé Processus De Fabrication
BRIEF published on 07/08/2026 at 19:16, 2 months 13 days ago GenSight Biologics présente sa situation financière et ses avancées thérapeutiques Trésorerie GenSight Biologics Phase III RECOVER GS010/LUMEVOQ® Accès Précoce
PRESS RELEASE published on 07/08/2026 at 19:11, 2 months 13 days ago Inside Information / News release on accounts, results GenSight Biologics reports cash position updates as of June 30, 2026, along with business developments, including proceeds from early access programs and manufacturing process improvements Cash Position Business Updates GenSight Biologics Early Access Programs Manufacturing Process
PRESS RELEASE published on 07/08/2026 at 19:11, 2 months 13 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation de trésorerie au 30 juin 2026 et fait un point sur son activité. La trésorerie est de 1,7 million d'euros, encaissant 6,8 millions d'euros au titre de ses programmes d'accès précoce Trésorerie GenSight Biologics Thérapies Géniques Neuropathie Optique Programmes D'accès Précoce
Published on 09/22/2026 at 15:25, 12 minutes ago Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 17 minutes ago MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 14:00, 1 hour 37 minutes ago GameSquare and Chartis Announce Strategic Data Partnership to Measure Brand and Creator Impact for User-Generated Content (UGC) Across Gaming
Published on 09/22/2026 at 14:00, 1 hour 37 minutes ago 374Water to Present New Supercritical Water Oxidation Destruction Data at WEFTEC 2026
Published on 09/22/2026 at 15:20, 17 minutes ago REHLKO DOUBLES ANNUAL BACKUP POWER CAPACITY AT CHANGZHOU MANUFACTURING FACILITY
Published on 09/22/2026 at 15:10, 27 minutes ago Ammonix Launches a New AI Architecture for High-Stakes Specialist Agents That Outperform Frontier Models at a Lower Cost
Published on 09/22/2026 at 15:10, 27 minutes ago Hollyland Introduces LARK M3: A Flexible & Scalable Wireless Audio System for Multi-Person and Multi-Camera Production
Published on 09/22/2026 at 15:05, 32 minutes ago More Than One-Third of Industrial Organizations See Cybersecurity Risk as a Top Obstacle to Growth, New Global Study Finds
Published on 09/21/2026 at 18:19, 21 hours 18 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 21 hours 18 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 21 hours 36 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 21 hours 51 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 21 hours 51 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
